Thesis
Risk factors for haemorrhage in patients with haematological malignancies
- Abstract:
-
Haematological malignancies and their treatment lead to prolonged periods of severe thrombocytopenia (platelet count ≤ 50 x 109/l). Despite the use of prophylactic platelet transfusions, haemorrhage remains an important complication during this thrombocytopenic period. Within a 30 day period up to 70% of patients have clinically significant haemorrhage (World Health Organization (WHO) grade 2 or above bleeding) and up to 10% have severe or life-threatening haemorrhage (WHO grade...
Expand abstract
Actions
Authors
Contributors
+ Murphy, M
Division:
MSD
Department:
RDM
Sub department:
RDM Clinical Laboratory Sciences
Role:
Supervisor
+ Stanworth, S
Division:
MSD
Department:
RDM
Sub department:
RDM Clinical Laboratory Sciences
Role:
Supervisor
Funding
Bibliographic Details
- Publication date:
- 2014
- Type of award:
- DPhil
- Level of award:
- Doctoral
- Awarding institution:
- University of Oxford
Item Description
- Language:
- English
- Keywords:
- Subjects:
- UUID:
-
uuid:4efbd9b1-62e5-4536-a5ee-df5eea4620d0
- Local pid:
- ora:9012
- Deposit date:
- 2014-10-06
Terms of use
- Copyright holder:
- Dr Lise Jane Estcourt
- Copyright date:
- 2014
- Notes:
- This thesis is not currently available in ORA.
If you are the owner of this record, you can report an update to it here: Report update to this record